Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| BIONTECH | 10 | 13 | +5,20 % | ||
| TRAVERE THERAPEUTICS | 8 | 11 | -16,33 % | ||
| ILLUMINA | 7 | - | +0,71 % | ||
| VERICEL | 5 | - | +1,91 % | ||
| BIOGEN | 4 | 54 | -3,68 % | ||
| AMGEN | 4 | 27 | -0,43 % | ||
| ALNYLAM PHARMACEUTICALS | 3 | 9 | +0,31 % | ||
| GILEAD SCIENCES | 3 | 5 | -0,40 % | ||
| APELLIS PHARMACEUTICALS | 3 | 4 | -5,83 % | ||
| LEXEO THERAPEUTICS | 3 | 3 | -8,50 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | JPM26: Biotech's M&A lift, the 'new' Biogen and Merck's $70B target | 2 | BioPharma Dive | ||
| Di | Eli Lilly Stock Rallies as Ventyx Deal Calms Wegovy Concerns | 4 | MarketBeat | ||
| Di | Faruqi & Faruqi LLP: INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics | 200 | Newsfile | Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses in Aquestive Therapeutics to Contact Him Directly to Discuss Their OptionsIf... ► Artikel lesen | |
| Di | Gentherapie-Entwickler Solid Biosciences meldet Fortschritte in klinischen Studien | 1 | Investing.com Deutsch | ||
| Di | Praxis Precision Medicines, Inc.: Praxis Precision Medicines Appoints Global Epilepsy Leader Dr. Orrin Devinsky as Head of Clinical Strategy | 3 | GlobeNewswire (USA) | ||
| Di | Solid Biosciences advances gene therapy trials for rare diseases | 1 | Investing.com | ||
| Di | Solid Biosciences Inc.: Solid Biosciences Provides 2026 Outlook Underscoring Neuromuscular and Cardiac Pipeline Momentum and Expanded Access to Next-Generation Capsid AAV-SLB101 | 2 | GlobeNewswire (USA) | ||
| Di | JPM26: Ionis, bolstered by strong launch of Tryngolza, doubles its sales projection in new indication to $2B | 4 | FiercePharma | ||
| Di | Foghorn Therapeutics, Inc.: Foghorn Therapeutics Announces Closing of $50 Million Registered Direct Financing at a 30% Premium | 1 | GlobeNewswire (USA) | ||
| Di | Crinetics Pharmaceuticals, Inc. - 8-K, Current Report | - | SEC Filings | ||
| Di | ACADIA PHARMACEUTICALS INC - 8-K, Current Report | - | SEC Filings | ||
| Di | BREAKING: Biontech im Kaufrausch - kommt jetzt der nächste Sprung? - jetzt lesen! | Hebelschein-Spekulant | |||
| Di | BioAge Labs extends rally after updating early-stage trial data for lead drug | 3 | Seeking Alpha | ||
| Di | Modella AI: AstraZeneca kauft KI-Firma zur Beschleunigung der Medikamentenentwicklung | 11 | manager-magazin.de | ||
| Di | IBD Stock Of The Day Medpace Tests Early Buy Point As Biotech Funding Shines | 1 | Investor's Business Daily | ||
| Di | RBC bestätigt Outperform-Rating für Biogen - Ausblick bleibt positiv | 7 | Investing.com Deutsch | ||
| Di | Biogen stock outlook remains positive as RBC reiterates Outperform rating | 3 | Investing.com | ||
| Di | Travere plummets as FDA extends Filspari review for rare kidney disorder | 2 | Seeking Alpha | ||
| Di | Grabar Law Office: Notice to Long-Term Shareholders of Lifecore Biomedical, Inc. (LFCR): Grabar Law Office Investigates Claims on Your Behalf as Securities Fraud Class Action Settles | 218 | Newsfile | Philadelphia, Pennsylvania--(Newsfile Corp. - January 13, 2026) - Grabar Law Office is investigating claims on behalf of shareholders of Lifecore Biomedical, Inc. (NASDAQ: LFCR) as a securities... ► Artikel lesen | |
| Di | FDA verlängert Prüffrist für FSGS-Medikament von Travere Therapeutics | 5 | Investing.com Deutsch |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .